UMIN ID: UMIN000000540
Registered date:10/12/2006
Fatty liver protection trial by Telmisartan or Losartan Study
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Hypertension with non alcoholic fatty liver disease |
| Date of first enrollment | 2006/12/01 |
| Target sample size | 130 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Telmisartan Losartan |
Outcome(s)
| Primary Outcome | Improvement of liver function (AST, ALT) |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Drug allergy for the agents. Severe liver dysfunction. Insulin treatment for diabetes mellistus. Malignancy. Recent major macrovascular disease. Severe hypertension. |
Related Information
| Primary Sponsor | Keio University, School of Medicine, Internal Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Keio University |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | 03-3353-1211(ext.62383) |
| Affiliation | Keio University, School of Medicine Internal Medicine |
| scientific contact | |
| Name | Toshihide Kawai |
| Address | 35 Shinanomachi, Shinjuku-ku,Tokyo Japan |
| Telephone | |
| Affiliation | Keio University, School of Medicine Internal Medicine, Endocrinology Metabolism |